Genentech Shows Off Positive Results From Phase III HEMLIBRA, TECENTRIQ Studies Post author:Sam Post published:November 19, 2017 Post category:BioPharma Data will be submitted to health authorities globally, including the FDA and EMA. Source: BioSpace You Might Also Like Finally! STADA Arzneimittel Accepts $5.6 Billion Takeover Offer From Cinven April 9, 2017 Akebia Announces $85M Public Offering March 22, 2018 Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017
Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017
